articleThe Lancet OncologyMar 26, 2012Closed access

Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial

KMKim MargolinMSMarc S. ErnstoffOHOmid HamidDPDonald P. LawrenceDFDavid F. McDermott

University of Washington · Dartmouth–Hitchcock Medical Center · +14 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,081
total citations
FWCI
67.26
Percentile
100%
References
37
Citations per year

Authors

15

Topics & keywords

Topics
Keywords
  • Medicine
  • Ipilimumab
  • Cohort
  • Internal medicine
  • Clinical endpoint
  • Asymptomatic
  • Melanoma
  • Surgery
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.